Detalhe da pesquisa
1.
Does early disease progression predict survival after first line-treatment of Waldenström macroglobulinemia?
Hematol Oncol
; 40(3): 400-408, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385885
2.
Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).
Haematologica
; 108(6): 1691-1696, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546425
3.
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
Hematol Oncol
; 35(4): 671-678, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27878835
4.
Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.
Am J Hematol
; 90(6): 511-4, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25752923
5.
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Am J Hematol
; 89(11): 1024-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052698
6.
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.
Cytokine
; 64(2): 523-31, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24008079
7.
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO).
Am J Hematol
; 93(2): E52-E54, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164674
8.
Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
Invest New Drugs
; 30(4): 1697-702, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21229289
9.
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
Vaccine
; 39(48): 7036-7043, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740475
10.
Assessing the impact of a quality improvement program on the quality and timeliness of discharge documents: A before and after study.
Medicine (Baltimore)
; 99(51): e23776, 2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33371146
11.
A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.
Neuro Oncol
; 21(8): 1039-1048, 2019 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31102405
12.
Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation.
Blood
; 118(2): 476-8, 2011 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21757631
13.
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
J Clin Oncol
; 34(18): 2125-32, 2016 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114594
14.
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
Neuro Oncol
; 18(9): 1297-303, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951382
15.
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's Lymphoma.
Clin Drug Investig
; 25(11): 719-29, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-17532718
16.
Pyogenic Granuloma During Ibrutinib Therapy for B-Cell Neoplasia.
JCO Oncol Pract
; 16(12): 834-836, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804585